INCENDIA PHARMA

Serial Number 79329010
Registration 7088835
700

Registration Progress

Application Filed
Oct 25, 2021
Under Examination
Approved for Publication
Apr 11, 2023
Published for Opposition
Apr 11, 2023
Registered
Jun 27, 2023

Trademark Image

INCENDIA PHARMA

Basic Information

Serial Number
79329010
Registration Number
7088835
Filing Date
October 25, 2021
Registration Date
June 27, 2023
Published for Opposition
April 11, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 27, 2023
Registration
Registered
Classes
005 042

Rights Holder

Incendia Pharma AB

64
Address
Södergatan 26
SE-211 34 Malmö
SE

Ownership History

Incendia Pharma AB

Original Applicant
64
SE

Incendia Pharma AB

Owner at Publication
64
SE

Incendia Pharma AB

Original Registrant
64
SE

Legal Representation

Attorney
Scott Rogers

USPTO Deadlines

Next Deadline
1446 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-06-27)
Due Date
June 27, 2029
Grace Period Ends
December 27, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description
Oct 16, 2023 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 27, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 27, 2023 FIMP P FINAL DISPOSITION PROCESSED
Sep 27, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Jun 27, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER
Jun 27, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 11, 2023 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 24, 2023 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 24, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 13, 2023 GPNX P NOTIFICATION PROCESSED BY IB
Apr 11, 2023 PUBO A PUBLISHED FOR OPPOSITION
Apr 11, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 22, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 22, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 22, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 9, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 7, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2022 RFNT P REFUSAL PROCESSED BY IB
Sep 29, 2022 RFRR P REFUSAL PROCESSED BY MPU
Sep 29, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 9, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 8, 2022 CNRT R NON-FINAL ACTION WRITTEN
Aug 2, 2022 DOCK D ASSIGNED TO EXAMINER
Jan 4, 2022 MAFR O APPLICATION FILING RECEIPT MAILED
Dec 29, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 23, 2021 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
Chemical preparations for medical, pharmaceutical or veterinary use, namely, for leaky gut, pulmonary diseases, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, inflammatory lung diseases, and gastrointestinal diseases; pharmaceutical preparations, namely, for leaky gut, pulmonary diseases, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, inflammatory lung diseases, and gastrointestinal diseases; pharmaceuticals, namely, gut microbiome stabilizators and quorum sensing inhibitors
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Pharmaceutical research and development
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA"